black box warning for glp 1 warnings: Definition, medications, and more Management of Obesity in Patients

For patients with an A1C of 6.5% to 7.5%, metformin is the preferred initial agent, with GLP-1 receptor agonists, dipeptidyl-peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), or an alpha-glucosidase inhibitor listed as viable alternatives

Providers should also assess for gastrointestinal side effects from tirzepatide and metabolic effects from prednisone, adjusting doses based on tolerance and glycemic response

& Atkin, S

Food and Drug Administration: Compounding and the FDA: Questions and Answers Prescription Drugs aand Over-the-Counter (OTC) Drugs: Questions and Answers

Angrisani, L

Thus, we cannot conclude that the improved health of the animals correlates with increased levels of GLP-1 in vivo and will likely need to move to a larger animal model to address this question